Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 1 to 10 of 42 resources
-
Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations
The WHO Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health response for five key populations (men who have sex with men, trans and gender diverse people, sex workers, people who inject drugs and people in prisons and other closed settings). They present and discuss new recommendations and consolidate a range of recommendations and guidance from current WHO guidelines.UK, Rest of World 01 Aug 2022 Reports & Research, Strategy & Planning PDF -
Drug-related infectious diseases in Europe: Update from the EMCDDA expert network, 2020
This 2020 update on drug-related infectious diseases from the EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) aims to provide a comprehensive overview of the current situation with regard to the epidemiological picture of drug-related infectious diseases in Europe up to January 2020. It highlights some recent innovative responses to the problem and argues that early diagnosis through testing as well as improving links to treatment and care are crucial steps towards reaching global health goals.UK, Rest of World Reports & Research, Strategy & Planning PDF -
World Hepatitis Alliance: 2019 Impact report
This report provides an overview of the World Hepatitis Alliance's impact in 2019, summarising key achievements in raising the importance of hepatitis elimination around the world.Rest of World 08 Apr 2020 Reports & Research PDF -
World Hepatitis Day 2019: Global Summary Report
The World Hepatitis Alliance has produced a report summarising activity for World Hepatitis Day 2019, including a global map of activity and regional reports.Rest of World 19 Dec 2019 Reports & Research PDF -
Legal Barriers for Providing HCV Community Testing in Europe
This report from the Correlation European Harm Reduction Network is based on a telephone survey conducted in September and October 2018 with representatives of harm reduction services and NGOs that offer low-threshold services to drug users.UK, Rest of World Reports & Research PDF -
EMCDDA on models of care for hepatitis C in drugs services
The European Monitoring Centre for Drugs and Drug Addiction published 'Hepatitis C: new models of care for drugs services' in July 2019. This aims to highlight the importance of targeting people who inject drugs as a key population for the elimination of hepatitis C in Europe and to show innovative practice in the form of 11 case studies (three of which are from England). The report provides key insights into the results, impact, sustainability and transferability of each practice to guide the implementation of these new models of care in other countries and settings.UK, Rest of World, England, Greater London 29 Jul 2019 Reports & Research, Strategy & Planning PDF -
Drug-related infectious diseases in Europe
This report from the European Monitoring Centre for Drugs and Drug Addiction provides an overview of infectious disease surveillance data, outbreak investigations, and prevention and control measures among people who inject drugs in Europe up to February 2019, including viral hepatitis.UK, Rest of World 16 Jul 2019 Reports & Research PDF -
Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners
This study evaluates peer-supported screening as a model of active HCV case finding within prisons with a secondary aim to describe the HCV cascade among those infected including linkage to care and treatment outcomes. The study was carried out in a medium-security Irish male prison with over 500 inmates. The authors conclude that peer-supported screening is an effective active HCV case-finding model to find and link prisoners with untreated active HCV infection to HCV care.Rest of World 09 Jul 2019 Reports & Research PDF -
WHO progress report on HIV, viral hepatitis and STIs 2019
The World Health Organisation has published its mid-term report on progress towards implementing the 'Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections'. The UK signed up to the 'Global health sector strategy on viral hepatitis 2016-21', committing to eliminating hepatitis C by 2030. The report highlights the need to strengthen data and update hepatitis data more regularly. It states that global targets for reducing mortality from viral hepatitis will not be met 'without massively accelerating universal access to testing' and treatment.Rest of World 24 May 2019 Reports & Research, Strategy & Planning PDF -
WHO policy brief on access to testing and treatment for people who inject drugs and people in prisons
The World Health Organisation (WHO) published this policy brief in April 2019 to set out the current landscape of country hepatitis policies for harm reduction and hepatitis C testing and treatment for people who inject drugs and people in prisons. It aims to capture how governments are translating the WHO Global health sector strategy on viral hepatitis 2016-2021, which the UK Government has signed up to, in national plans. It also provides a summary of the enablers and barriers to hepatitis C testing and treatment in these populations.UK, Rest of World 17 May 2019 Reports & Research, Tools & Templates, Strategy & Planning PDF